Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.

@article{Man2015SuppressionOS,
  title={Suppression of SOX7 by DNA methylation and its tumor suppressor function in acute myeloid leukemia.},
  author={Cheuk Him Man and Tsz Kan Fung and Haixia Wan and Chae Yin Cher and August Fan and Nelson Ka-Lam Ng and Christa Ho and Thomas Shek-Kong Wan and Toshiyuki Tanaka and Chi Wai Eric So and Yok-lam Kwong and Anskar Y H Leung},
  journal={Blood},
  year={2015},
  volume={125 25},
  pages={
          3928-36
        }
}
SOX7 belongs to the SOX (Sry-related high-mobility group [HMG] box) gene family, a group of transcription factors containing in common a HMG box domain. Its role in hematologic malignancies and, in particular, acute myeloid leukemia (AML) is completely unknown. Here, we showed that SOX7 expression was regulated by DNA hypermethylation in AML but not in acute lymphoblastic leukemia or normal bone marrow cells. In cell lines (KG1, ML2, and K562) and in primary CD34(+) AML samples, SOX7 expression… Expand
SOX12: a novel potential target for acute myeloid leukaemia
TLDR
SOX12 may be involved in leukaemia progression by regulating the expression of β‐catenin and then interfering with TCF/Wnt pathway, which may be a target for AML. Expand
Diverse pathogenetic roles of SOX genes in acute myeloid leukaemia and their therapeutic implications.
TLDR
Studying the diverse pathogenetic roles of SOX genes in AML may shed lights to the heterogeneity of AML and generate information that can be translated into novel therapeutic strategies. Expand
Identification and validation of SRY-box containing gene family member SOX30 methylation as a prognostic and predictive biomarker in myeloid malignancies
TLDR
The findings revealed that SOX30 methylation was associated with disease progression in MDS and acted as an independent prognostic and predictive biomarker in AML. Expand
Prognostic significance of SOX2, SOX3, SOX11, SOX14 and SOX18 gene expression in adult de novo acute myeloid leukemia.
TLDR
It is found that these genes are overexpressed in 10-22% of patients and preliminary findings suggest that high expression level of these genes may have prognostic significance in AML patients. Expand
SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cells
TLDR
It is shown that SOX7 was significantly downregulated in different cancer types, especially in lung and breast cancers, and Panobinostat, an FDA approved pan-HDAC inhibitor, could elevate and restore SoX7 expression in SOX6 silenced lung cancer cells. Expand
SOX7 promotes the maintenance and proliferation of B cell precursor acute lymphoblastic cells.
TLDR
It is established that the down-regulation of SOX7 in BCP-ALL causes a significant decrease in proliferation and clonogenicity in vitro that correlates with a delay in leukemia initiation and burden in vivo. Expand
SOX7 methylation is an independent prognostic factor in myelodysplastic syndromes.
TLDR
It is demonstrated that SOX7 methylation conferred adverse prognosis in myelodysplastic syndrome patients and was associated with leukemia progression. Expand
Long noncoding RNA AB073614 promotes the malignance of glioma by activating Wnt/β-catenin signaling through downregulating SOX7.
TLDR
It is demonstrated that AB073614 promoted the progression of glioma by targeting SOX7 to activate the Wnt/β-catenin signaling pathway, suggesting that the inhibition of AB73614 might be a potential target for therapeutic intervention in gliomas patients. Expand
SOX13 promotes colorectal cancer metastasis by transactivating SNAI2 and c-MET
TLDR
SoX13 is a promising prognostic biomarker in patients with CRC, and blocking the HGF/STAT3/SOX13/c-MET axis with crizotinib could be a new therapeutic strategy to prevent SOX13-mediated CRC metastasis. Expand
MiR-595 targeting regulation of SOX7 expression promoted cell proliferation of human glioblastoma.
TLDR
Observations indicated that miR-595 played a critical role in carcinogenesis by suppression of SOX7, and may serve as a therapeutic target for the treatment of GBM. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 46 REFERENCES
Expression of human SOX7 in normal tissues and tumors.
  • M. Katoh
  • Medicine, Biology
  • International journal of molecular medicine
  • 2002
TLDR
SOX7 gene might be one of cancer-associated genes on human chromosome 8p22, and SOX7 mRNA was relatively highly expressed in adult lung, trachea, lymph node, placenta, fetal lung, and heart, but was significantly down-regulated in 7 out of 18 cases of primary colorectal tumors. Expand
SOX7: from a developmental regulator to an emerging tumor suppressor.
TLDR
Recent studies demonstrate a tumor suppressive role of SOX7 in a xenograft mouse model, and unravel that many genes regulating cell death, growth and apoptosis are affected by SoX7, strongly supporting a pivotal role of SoX8 in tumorigenesis. Expand
Methylation of the CpG island near SOX7 gene promoter is correlated with the poor prognosis of patients with myelodysplastic syndrome.
TLDR
Patients with the methylation of the CpG island of the SOX7 gene can be used as a predictive factor for the development and prognosis of MDS patients, according to prognostic analysis and methylation-specific PCR. Expand
SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells.
TLDR
Restoration of SOX7 induced colorectal cancer cell apoptosis, inhibited cell proliferation and colony formation, and efficiently suppressed beta-catenin-mediated transcriptional activity. Expand
Sox7 Is an Independent Checkpoint for β-Catenin Function in Prostate and Colon Epithelial Cells
TLDR
It is discovered that Sox7 protein physically interacts with β-catenin and suppresses β- catenin–mediated transcription by depleting active β-Catenin, and suggests that Sox 7 is a tumor suppressor that functions as an independent checkpoint for β-catsenin transcriptional activity. Expand
Characterization of Tumor-Suppressive Function of SOX6 in Human Esophageal Squamous Cell Carcinoma
TLDR
It is provided the first evidence that SOX6 is a novel tumor-suppressor gene in ESCC development and is a potential prognostic marker inESCC. Expand
The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AML
TLDR
It is shown that the Wnt/β-catenin signaling pathway is required for self-renewal of LSCs that are derived from either hematopoietic stem cells (HSC) or more differentiated granulocyte-macrophage progenitors (GMP). Expand
Sox17 and Sox4 Differentially Regulate β-Catenin/T-Cell Factor Activity and Proliferation of Colon Carcinoma Cells
TLDR
Results indicate that Sox proteins can act as both antagonists and agonists of β-catenin/TCF activity, and this mechanism may regulate Wnt signaling responses in many developmental and disease contexts. Expand
Down-regulation of Sox7 is associated with aberrant activation of Wnt/β-catenin signaling in endometrial cancer
TLDR
Sox7 is a negative regulator of Wnt/β-catenin signaling pathway through impeding the transcriptional machinery of β- catenin/TCF/LEF-1 transcriptional complex, and the loss of expression may be involved in the pathogenesis of endometrial cancer. Expand
The Wnt signaling pathway regulates Nalm-16 b-cell precursor acute lymphoblastic leukemic cell line survival and etoposide resistance.
TLDR
The results suggest that canonical activation of the Wnt pathway may exerts a tumor suppressive effect, thus its inhibition may support BCP-ALL cell survival. Expand
...
1
2
3
4
5
...